Mymetics

OverviewSuggest Edit

Mymetics develops nex-generation prophylactic vaccines for infectious diseases. Its vaccines are designed to induce protection against early transmission and infection, focusing both on the mucosal immune response as a first-line defense and the systemic blood immune response. 

The company's approach has resulted in the development of a rich pipeline of vaccine candidates for HIV-1/AIDS, intra nasal Influenza, Malaria, Herpes Simplex Virus and the Respiratory Syncytial Virus vaccine.

TypePublic
Founded1994
HQÉpalinges, CH
Websitemymetics.com
Employee Ratings3

Latest Updates

Employees (est.) (Feb 2019)9
Revenue (FY, 2018)$967 (-36%)

Key People/Management at Mymetics

Ronald Kempers

Ronald Kempers

President, Chief Executive Officer and Chief Financial Officer
Mario Amacker

Mario Amacker

Head of Quality and Manufacturing
Sylvain Fleury

Sylvain Fleury

Chief Scientific Officer
Toon Stegmann

Toon Stegmann

Chief Scientific Officer Mymetics BV – Head R&D
Show more

Mymetics Office Locations

Mymetics has an office in Épalinges
Show all (1)

Mymetics Financials and Metrics

Mymetics Revenue

Mymetics's revenue was reported to be $967 in FY, 2018
USD

Net income (Q1, 2019)

(1.2k)

EBIT (Q1, 2019)

(559.0)

Cash (31-Mar-2019)

475.0
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

4.4m2.4m3.2k1.3m1.5k967.0

Revenue growth, %

(45%)31%(60%)

General and administrative expense

1.4m1.3m1.5k1.2m1.2k1.1k

R&D expense

657.0k1.6m1.7k1.0m2.1k1.2k
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

527.0k515.0k635.0k662.0k1.0k694.0405.0323.0179.0383.0317.0399.0297.0189.0274.0

General and administrative expense

382.0k292.0k369.0k393.0k447.0376.0343.0289.0298.0330.0294.0276.0277.0236.0319.0278.0

R&D expense

369.0k372.0k396.0k367.0k554.0455.0109.0249.0241.0667.0300.0555.0308.0271.0343.0215.0

Operating expense total

1.4m1.3m765.0k760.0k941.0838.0376.0605.0536.0976.0437.0769.0533.0659.0685.0559.0
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Cash

297.0k2.4k1.4m1.2k479.0

Accounts Receivable

3.7m218.090.0585.0

Current Assets

4.1m2.7k1.6m1.3k1.1k

Goodwill

6.7m6.7k6.7m6.7k6.7k
Quarterly
USDQ1, 2014Q2, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

1.7m1.3m3.2k2.6k2.0k1.5k1.1k1.5k1.6k830.0545.0843.0254.0475.0

Accounts Receivable

112.0151.057.0155.0348.048.0

Current Assets

2.1m1.7m3.6k2.9k2.2k1.7k1.2k1.8k1.7k927.0652.01.0k640.0567.0

Goodwill

6.7m6.7m6.7k6.7k6.7k6.7k6.7k6.7k6.7k6.7k6.7k6.7k6.7k6.7k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

6.0m(3.3m)(3.0k)(6.0m)(4.1k)(4.2k)

Depreciation and Amortization

20.0k33.0k43.042.0k39.029.0

Accounts Payable

(467.0k)(133.0k)(393.0)(212.0k)117.0(162.0)

Cash From Operating Activities

(4.3m)3.0m730.0(987.0k)(2.5k)(2.3k)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Net Income

(909.0k)(1.7m)(2.6m)(953.0k)(1.5k)(2.3k)(593.0)(1.5k)(2.5k)(1.2k)(2.0k)(3.0k)(898.0)(2.0k)(3.1k)(1.2k)

Depreciation and Amortization

7.0k16.0k24.0k10.0k19.032.010.022.033.09.018.028.08.016.023.05.0

Accounts Payable

(201.0k)(406.0k)(319.0k)112.0k338.016.0(271.0)(352.0)(341.0)(21.0)(81.0)(24.0)(166.0)(210.0)(179.0)(39.0)

Cash From Operating Activities

2.3m1.3m599.0k39.0k1.5k1.0k(378.0)(878.0)(1.3k)(988.0)(873.0)(1.7k)(634.0)(1.1k)(1.7k)(9.0)
USDY, 2019

Financial Leverage

-0.2 x
Show all financial metrics

Mymetics News and Updates

New Mymetics data to be presented by LMIV at American Society of Tropical Medicine and Hygiene

EPALINGES, Switzerland, Oct. 30, 2018 /PRNewswire/ -- Mymetics Corporation (OTCQB: MYMX), a pioneer and leader in the research and development of virosome-based vaccines against life threatening and life disabling diseases announces that new data will be presented at the 67th American...

Mymetics Frequently Asked Questions

  • When was Mymetics founded?

    Mymetics was founded in 1994.

  • Who are Mymetics key executives?

    Mymetics's key executives are Ronald Kempers, Mario Amacker and Sylvain Fleury.

  • How many employees does Mymetics have?

    Mymetics has 9 employees.

  • What is Mymetics revenue?

    Latest Mymetics annual revenue is $967 .

  • What is Mymetics revenue per employee?

    Latest Mymetics revenue per employee is $107 .

  • Who are Mymetics competitors?

    Competitors of Mymetics include Obsidian Therapeutics, Elite Pharmaceuticals and Amarillo Biosciences.

  • Where are Mymetics offices?

    Mymetics has an office in Épalinges.

  • How many offices does Mymetics have?

    Mymetics has 1 office.